Lixisenatide acetate

CAS No. 1997361-87-1

Lixisenatide acetate( —— )

Catalog No. M30168 CAS No. 1997361-87-1

Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 112 In Stock
10MG 183 In Stock
25MG 307 In Stock
50MG 431 In Stock
100MG 586 In Stock
200MG 789 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lixisenatide acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
  • Description
    Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GLP-1 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1997361-87-1
  • Formula Weight
    5218.79
  • Molecular Formula
    C215H347N61O65S.6C2H4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 50 mg/mL (9.58 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Obtusalin

    Obtusalin is a triterpenoid found in R. dauricum for the first time and shows UV absorption at 210 nm.

  • [D-Arg25]-Neuropepti...

    [D-Arg25]-Neuropeptide Y, human, rat; [D-Arg25]-NPY, human, rat

  • Rusalatide acetate

    Rusalatide acetate (TP508 amide acetate), a regenerated peptide, alleviates radiation-induced gastrointestinal injury by activating stem cells and protecting recess integrity.